ECR 2025
ECR 2025 – European Society of Radiology
AI-27 – Hall X1 | Vienna, Austria | February 26 – March 2, 2025
It’s About Time.
To elevate breast health with precision and clarity.
Her breast health journey deserves trust and confidence—empower it with iCAD’s AI-powered solutions, offering faster, more precise insights to help you deliver exceptional care today—and tomorrow. With iCAD, reduce diagnostic uncertainty and ensure she gets the right care at the right time, giving her confidence and peace of mind.
Learn how iCAD’s AI solutions can elevate your breast health approach.
Cancer wins when it hides.
When it comes to cancer, hide and seek is no game.
iCAD is creating a world where cancer can’t hide with innovative artificial intelligence solutions that empower providers and professionals to accurately, reliably and quickly detect cancer and improve outcomes – optimizing every patient’s opportunity to live better, longer lives.
ProFound on Stage: 2025 Event Program
Scientific Presentations
Yinhao Ren, PhD, Senior AI Research Scientist, iCAD, Inc.
Rapid Prototyping of a Breast Arterial Calcification Detection Algorithm with Human-in-the-Loop Annotation
- Abstract Poster
- February 26 – March 2, 2025
Mikael Eriksson, Karolinska institutet
A 10-year image-derived AI risk model for use in primary prevention of breast cancer
- Research Presentation Session: RPS 1002
- February 27, 2025 | 14:00 – 15:30 CET
Emily F. Conant, MD, University of Pennsylvania
Short-term risk prediction of breast cancer comparing risk tools for digital mammography and digital breast tomosynthesis in U.S. screening populations
- Research Presentation Session: RPS 2202
- March 2, 8:00-9:00am CET
NEW! ProFound Cloud.
Speed, Scalabe, and Secure.
iCAD’s ProFound Cloud-based Software as a Service (SaaS) model, offers healthcare providers flexible, scalable access to iCAD’s ProFound full suite of solutions, including DBT Detection, 2D Detection, Density Assessment, and Risk. The model supports exam-based pricing, while ensuring seamless integration with existing workflows and compliance with healthcare systems and PACS platforms.
Discover the Improved Readability in ProFound AI Detection V3 Service Pack.
Radiologists Asked. We Delivered.
New features help breast imaging professionals quickly identify suspicious lesions by limiting the number of marks on each 3D view, and understand the level of suspicion related to lesions and the case through color-coded scoring ranges.
Improved Readability on Workstation:
• Limited number of marks
• Color-coded lesion marks
• Color-coded scorecard
Introducing iCAD’s AI Platform
ProFound Breast Health Suite
Powered by the latest innovations in artificial intelligence (AI), the ProFound Suite offers clinically proven, 360-degree solutions for cancer detection, density assessment, and personalized risk evaluation. With about 2x improvement in clinical performance compared to other AI platforms,1 ProFound offers unrivaled accuracy, as well as multi‐vendor compatibility and unique workflow advantages.
Joining forces against a common enemy.
In the fight against cancer, we’re stronger together. Learn why our customers believe that our solutions are the secret weapon for cancer detection and treatment.
“Profound AI is my best friend radiologist, looking over my shoulder, never tired and always available”.
DR. ISABELLE BILTJES
RAdiollogits, AZ Klina, Brasschaat, Belgium
I was delighted with my collaboration with the IntelliMed team. They accompanied us throughout the process of upgrading to artificial intelligence, from the decision to choose iCAD’s breast AI solutions, such as ProFound AI, to their seamless integration into our daily workflow. As an imaging center specializing in women’s healthcare, knowledge and understanding of the space were essential to ensure the project was a success.
ELENA CAUZZA
Radiologist at Radiomedica and xDonna, a mammography and breast diagnosis center in Bellinzona, Switzerland
“We can see the percentage rating of each tumor on the screen, which aids in determining if a suspicious finding needs further workup. The software shortens radiologists’ reading times and enables quick and safe decision-making that helps us avoid unnecessary recalls and tests for patients. iCAD has developed an excellent high-level technology. As a radiologist, I can say that this is the first AI product I have used that enhances my workflow and I trust the results”.
AHUVA GRUBSTAIN
Head of Breast Imaging Unit, Department of Imaging, Rabin Medical Center, Hasharon, Israel, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
“When breast cancer is diagnosed early, survival after treatment is excellent, over 90% in some countries. At C.S.E., we have been using ProFound AI for 2D Mammography and DBT for several years, during which we have seen iCAD’s constant commitment to improve performance in terms of both sensitivity and specificity as new versions are released”.
PATRICK TOUBIANA
MD, Radiologist, President and Co-Founder at the C.S.E. Centre Imagerie Médicale Numérique, Paris, France
Patient-Driven, AI-Powered
Creating a World Where Cancer Can’t Hide.
Implementation made easy.
Streamlining mammography workflows to create efficiencies and peace of mind.
With thousands of installations worldwide, our solutions offer multi-vendor compatibility that seamlessly integrate into the diagnostic process, in any reading environment.
Flexible turnkey solutions and service options designed to meet your unique deployment needs
ProFound Cloud
Connect via your private cloud, AI-marketplace, or directly with iCAD’s native cloud and support plans.
ProFound On-Premises
Onsite hardware conveniently pre-loaded with iCAD software plus warranty and service plans.
Interoperability: 50+ PACS & 94 versions | 2D & 3D OEM manufacturers | AI platform providers & workflow systems
Let’s Connect at ECR
We look forward to meeting with you.
Schedule a time to connect with us live or virtually to discuss how iCAD’s ProFound AI Breast Health Suite of solutions can best support your current workflow needs.